Zhejiang University Science and Technology Venture Capital

Investment oversight flows through the parent Holding Group's board, which reflects the 80% ownership stake of the Zhejiang Provincial SASAC and the university's commercial-appointments committee. Day-to-day investment committee decisions are made in coordination with the university's technology-transfer office, which evaluates the scientific merit of spinout technologies before they reach the venture arm's portfolio. The firm's governance ties SASAC capital-allocation targets to the university's patent pipeline, creating a dual-approval process not typical of standalone venture firms.

The firm spans the entire venture lifecycle — seed, start-up, expansion, and late-stage growth — but its engine room is the translation of lab-stage IP into seed and start-up rounds. It follows these initial positions into later rounds, often via co-investment structures with provincial funds that provide scale-up capital for industrial facilities, particularly in advanced chemicals and automation.

The majority of the firm's capital base originates with the Zhejiang Provincial SASAC, which holds an 80% stake in the parent Holding Group. Additional capital flows indirectly through the Zhejiang University Education Foundation and co-investment partnerships with state-owned enterprises such as Wuchan Zhongda Group. The firm's balance sheet is therefore a hybrid of provincial state capital and university-affiliated institutional assets.

Confirmed exposure areas include advanced chemicals and materials — particularly fluorochemicals via the Quzhou fund — industrial automation, AI and machine learning applied to process control, healthcare services arising from the university's medical school, and dual-use technologies with both civilian and defense-adjacent applications. The firm targets sectors where Zhejiang University holds a national-research-lab advantage and where Zhejiang Province maintains explicit industrial-development priorities.